Literature DB >> 15050227

Rare localization of a portal cavernoma in the wall of the common bile duct.

S Novellas1, P Chevallier, J L Peroux, J-N Bruneton.   

Abstract

The first communication on biliary complications secondary to a portal cavernoma was published in 1965 [Br. J. Surg. 52 (1965) 636.], and since then several cases have been reported in the medical literature. These biliary complications, studied initially by anterograde or retrograde cholangiography, and later MR cholangiography [Van Hoe L, Van Beckevoort D, Van Steenbergen W. Atlas of across-sectional and projective MR cholangiography. Berlin: Springer; 1999. p. 166-7.], appear to be secondary to a double mechanism which produces a compression of the common bile duct (CBD) and ischemic changes. The biliary abnormalities most frequently found are a dilatation of the intrahepatic biliary ducts associated with extrinsic strictures and segmental dilatation of the CBD [J. Radiol. 83 (2001) 341.]. We report a rare type of portal cavernoma characterized by a thickening of the walls of the CBD and by a dilatation of the intrahepatic biliary ducts. The thickened walls of the CBD were evaluated by ultrasound and by magnetic resonance imaging.

Entities:  

Mesh:

Year:  2004        PMID: 15050227     DOI: 10.1016/S0899-7071(04)00002-6

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  3 in total

Review 1.  Portal cavernoma cholangiopathy: an endoscopic ultrasound based imaging approach.

Authors:  Malay Sharma; Chittapuram S Rameshbabu
Journal:  J Clin Exp Hepatol       Date:  2013-09-26

Review 2.  Pathogenesis of Portal Cavernoma Cholangiopathy: Is it Compression by Collaterals or Ischemic Injury to Bile Ducts During Portal Vein Thrombosis?

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-01-02

3.  Whole clinical process in a patient with portal hypertensive biliopathy: a case report.

Authors:  Yimin Ma; Rencheng Cai; Duanming Zhuang; Yuehua Tang; Youhong Cao; Xiaoping Wang; Zhenguo Qiao
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.